Mind Medicine (MindMed) (MNMD) News Today $7.16 +0.15 (+2.14%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Chardan Capital Initiates Coverage of Mind Medicine (MNMD) with Buy RecommendationDecember 20 at 3:35 PM | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Chardan CapitalChardan Capital started coverage on Mind Medicine (MindMed) in a report on Friday. They issued a "buy" rating and a $20.00 price target on the stock.December 20 at 8:31 AM | marketbeat.comWellington Management Group LLP Purchases 109,152 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Wellington Management Group LLP raised its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 142.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,722 shares of the company's stock aftDecember 20 at 3:39 AM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 4.9% - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 4.9% Higher - Here's WhyDecember 18 at 1:54 PM | marketbeat.comMind Medicine (MindMed)'s (MNMD) Outperform Rating Reaffirmed at OppenheimerDecember 18 at 3:49 AM | americanbankingnews.comMind Medicine (MindMed) (NASDAQ:MNMD) Receives Outperform Rating from OppenheimerOppenheimer reaffirmed an "outperform" rating and set a $20.00 price target on shares of Mind Medicine (MindMed) in a research report on Tuesday.December 17, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from BrokeragesDecember 16, 2024 | americanbankingnews.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from BrokeragesMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven research firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation and three have issuDecember 16, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3% - Time to Sell?November 29, 2024 | marketbeat.comAlly Bridge Group NY LLC Sells 176,918 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Ally Bridge Group NY LLC lowered its holdings in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 18.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 788,508 shares of the company's stock after sellingNovember 28, 2024 | marketbeat.comQ3 EPS Estimate for Mind Medicine (MindMed) Cut by AnalystMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Roth Capital lowered their Q3 2025 earnings estimates for shares of Mind Medicine (MindMed) in a report issued on Tuesday, November 19th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.November 22, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from AnalystsShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been assigned a consensus rating of "Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy rating and three have given a strNovember 21, 2024 | marketbeat.comMindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance OfficerNovember 19, 2024 | finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's WhyNovember 15, 2024 | marketbeat.comMind Medicine (MindMed) Sees Unusually High Options Volume (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) was the target of unusually large options trading activity on Friday. Traders acquired 4,593 call options on the stock. This is an increase of approximately 180% compared to the typical daily volume of 1,638 call options.November 15, 2024 | marketbeat.comMind Medicine Set to Engage at Key Investor ConferencesNovember 14, 2024 | markets.businessinsider.comMindMed to Participate in Upcoming Investor ConferencesNovember 13, 2024 | businesswire.comMind Medicine (MindMed)'s (MNMD) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $55.00 price objective on shares of Mind Medicine (MindMed) in a research note on Monday.November 11, 2024 | marketbeat.comOptimistic Outlook for Mind Medicine Amidst Promising Phase 3 Developments and Robust Financial HealthNovember 11, 2024 | markets.businessinsider.comMind Medicine: No News = Good NewsNovember 10, 2024 | seekingalpha.comMind Medicine’s Promising Potential and Financial Strength Justify Buy RatingNovember 10, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Mind Medicine (MNMD)November 9, 2024 | markets.businessinsider.comMindMed Advances Phase 3 Trials in Mental HealthNovember 9, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comMindMed Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 7, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 10.1% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 10.1% - Time to Buy?November 7, 2024 | marketbeat.comMind Medicine (MindMed) (MNMD) Scheduled to Post Earnings on ThursdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639533)October 31, 2024 | marketbeat.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business UpdateOctober 24, 2024 | finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Raised to "Strong-Buy" at Leerink PartnrsLeerink Partnrs upgraded Mind Medicine (MindMed) to a "strong-buy" rating in a research report on Friday.October 15, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink PartnersLeerink Partners started coverage on shares of Mind Medicine (MindMed) in a research note on Monday. They issued an "outperform" rating and a $20.00 price objective on the stock.October 14, 2024 | marketbeat.comMind Medicine assumed with an Outperform at LeerinkOctober 13, 2024 | finance.yahoo.comMind Medicine (NASDAQ:MNMD) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received an average rating of "Buy" from the twelve ratings firms that are currently covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and two have assiOctober 2, 2024 | marketbeat.comMarshall Wace LLP Grows Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Marshall Wace LLP lifted its holdings in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 8.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,160,203 shares of the company's stock after buying an additional 161,659 shares duringSeptember 28, 2024 | marketbeat.comCarrie Liao Sells 2,352 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockSeptember 26, 2024 | insidertrades.comRhumbline Advisers Invests $679,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Rhumbline Advisers purchased a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 94,116 shares of the company's stock, valued at approximateSeptember 25, 2024 | marketbeat.comGritstone bio, Inc. (2JQ.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Bank of New York Mellon CorpBank of New York Mellon Corp lifted its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 472.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 246,208 shares of the company's stock after buying aSeptember 19, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $14.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their target price on Mind Medicine (MindMed) from $16.00 to $14.00 and set a "buy" rating on the stock in a research note on Monday.September 16, 2024 | marketbeat.comMindMed Announces New Employee Inducement GrantsSeptember 11, 2024 | finance.yahoo.comQ3 2024 Earnings Forecast for Mind Medicine (MindMed) Inc. Issued By HC Wainwright (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at HC Wainwright boosted their Q3 2024 earnings per share (EPS) estimates for shares of Mind Medicine (MindMed) in a note issued to investors on Thursday, August 29th. HC Wainwright analyst P. Trucchio now expecSeptember 2, 2024 | marketbeat.comMind Medicine Inc (MMQ.DU)August 29, 2024 | sg.finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $55.00 at HC WainwrightHC Wainwright lifted their target price on shares of Mind Medicine (MindMed) from $35.00 to $55.00 and gave the stock a "buy" rating in a report on Thursday.August 29, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Director David W. Gryska Acquires 3,500 SharesAugust 27, 2024 | insidertrades.comQ3 2024 Earnings Estimate for Mind Medicine (MindMed) Inc. Issued By Leerink Partnrs (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at Leerink Partnrs increased their Q3 2024 earnings per share (EPS) estimates for Mind Medicine (MindMed) in a research note issued on Tuesday, August 13th. Leerink Partnrs analyst R. Li now forecasts that the cAugust 16, 2024 | marketbeat.comMindMed Reports Second Quarter 2024 Financial Results and Business UpdatesAugust 14, 2024 | finance.yahoo.comSmall Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology BetAugust 14, 2024 | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $6.85Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $6.85August 13, 2024 | marketbeat.comPacific Defense Announces US Army CMFF Program TeamAugust 13, 2024 | businesswire.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy this coin BEFORE Inauguration Day … (Ad)Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office. This could be his favorite coin. MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.550.60▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼103▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TLRY News CRON News USNA News CDXC News BTMD News CGC News ACB News MDWD News FTLF News NAII News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
